Lab-On-A-Chip for the Development of Pro-/Anti-Angiogenic Nanomedicines to Treat Brain Diseases

There is a huge demand for pro-/anti-angiogenic nanomedicines to treat conditions such as ischemic strokes, brain tumors, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Nanomedicines are therapeutic particles in the size range of 10–1000 nm, where the drug is encapsulated into n...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramaniyan Parimalam, Subhathirai, Badilescu, Simona, Sonenberg, Nahum, Bhat, Rama, Packirisamy, Muthukumaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940944/
https://www.ncbi.nlm.nih.gov/pubmed/31817343
http://dx.doi.org/10.3390/ijms20246126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940944/
https://www.ncbi.nlm.nih.gov/pubmed/31817343
http://dx.doi.org/10.3390/ijms20246126

Ejemplares similares